Role of Myeloperoxidase as Predictor of Systemic Inflammatory Response Syndrome in Patients With ST-Segment Elevation Myocardial Infarction After Primary Percutaneous Coronary Intervention

American Journal of Cardiology

Volumn 104, Issue 5, 2009, Pages 634-637

  Samimi Fard, Sima ^a   Dominguez Rodriguez, Alberto ^a   Abreu Gonzalez, Pedro ^b   Enjuanes Grau, Cristina ^a   Blanco Palacios, Gabriela ^a   Hernandez Baldomero, Idaira F ^a   Bosa Ojeda, Francisco ^a   Marrero Rodríguez, Francisco ^a  

^a HOSPITAL UNIVERSITARIO DE CANARIAS   (Spain)

^b UNIVERSIDAD DE LA LAGUNA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

MYELOPEROXIDASE;

ADULT; AGED; ANGIOGRAPHY; ARTICLE; BREATHING RATE; CONFIDENCE INTERVAL; CONTROLLED STUDY; CORONARY CARE UNIT; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEART INFARCTION; HEART RATE; HOSPITAL ADMISSION; HOSPITALIZATION; HUMAN; LABORATORY TEST; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PRIORITY JOURNAL; RISK; ST SEGMENT ELEVATION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

AGED; ANGIOPLASTY, TRANSLUMINAL, PERCUTANEOUS CORONARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; MALE; MIDDLE AGED; MYOCARDIAL INFARCTION; PEROXIDASE; PREDICTIVE VALUE OF TESTS; PROGNOSIS; REPERFUSION INJURY; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME;

EID: 68749102093     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.amjcard.2009.04.049     Document Type: Article

References (26)

1. Hochman J.S., Sleeper L.A., Webb J.C., Sanborn T.A., White H.D., Talley J.D., Buller C.E., Jacobs A.K., Slater J.N., Col J., Mckinlay S.M., and LeJemtel T.H. Early revascularization in acute myocardial infarction complicated by cardiogenic shock. SHOCK Investigators. Should we emergently revascularize occluded coronary arteries for cardiogenic shock. N Engl J Med 341 (1999) 625-634
2. Bone R.C. Toward a theory regarding the pathogenesis of the systemic inflammatory response syndrome: what we do and do not know about cytokine regulation. Crit Care Med 24 (1996) 163-172
3. Neumann F.J., Ott I., Gawaz M., Richardt G., Holzapfel H., Jochum M., and Schömig A. Cardiac release of cytokines and inflammatory responses in acute myocardial infarction. Circulation 92 (1995) 748-755
4. Kohsaka S., Menon V., Lowe A.M., Lange M., Dzavik V., Sleeper L.A., Hochman J.S., and SHOCK Investigators. Systemic inflammatory response syndrome after acute myocardial infarction complicated by cardiogenic shock. Arch Intern Med 165 (2005) 1643-1650
5. Haverkate F., Thompson S.G., Pyke S.D., Gallimore J.R., and Pepys M.B. European Concerted Action on Thrombosis and Disabilities Angina Pectoris Study Group. Production of C-reactive protein and risk of coronary events in stable and unstable angina. Lancet 349 (1997) 462-466
6. Hochman J.S. Cardiogenic shock complicating acute myocardial infarction: expanding the paradigm. Circulation 107 (2003) 2998-3002
7. Zhang R., Brennan M.L., Shen Z., Macpherson J.C., Schmitt D., Molenda C.E., and Hazen S.L. Myeloperoxidase functions as a major enzymatic catalyst for initiation of lipid peroxidation at sites of inflammation. J Biol Chem 277 (2002) 46116-46122
8. Dominguez-Rodriguez A., Samimi-Fard S., Abreu-Gonzalez P., Garcia-Gonzalez M.J., and Kaski J.C. Prognostic value of admission myeloperoxidase levels in patients with ST-segment elevation myocardial infarction and cardiogenic shock. Am J Cardiol 101 (2008) 1537-1540
9. Levy M.M., Fink M.P., Marshall J.C., Abraham E., Angus D., Cook D., Cohen J., Opal S.M., Vincent J.L., and Ramsay G. SCMM/ESICM/ACCP/ATS/SIS. 2001 SCMM/ESICM/ACCP/ATS/SIS International Sepsis Definition Conference. Intens Care Med (2001) 530-538
10. Holmes Jr. D.R. Cardiogenic shock: a lethal complication of acute myocardial infarction. Rev Cardiovasc Med 4 (2003) 131-135
11. Brennan M.L., Penn M.S., Van Lente F., Nambi V., Shishehbor M.H., Aviles R.J., Goormastic M., Pepoy M.L., McErlean E.S., Topol E.J., Nissen S.E., and Hazen S.L. Prognostic value of myeloperoxidase in patients with chest pain. N Engl J Med 349 (2003) 1595-1604
12. Baldus S., Heeschen C., Meinertz T., Zeiher A.M., Eiserich J.P., Munzel T., Simoons M.L., Hamm C.W., and CAPTURE Investigators. Myeloperoxidase serum levels predict risk in patients with acute coronary syndromes. Circulation 108 (2003) 1440-1445
13. Cavusoglu E., Chopra V., Gupta A., Ruwende C., Yanamadala S., Eng C., Clark L.T., Pinsky D.J., and Marmur J.D. Usefulness of the white blood cell count as a predictor of angiographic findings in an unselected population referred for coronary angioplasty. Am J Cardiol 98 (2006) 1189-1193
14. Cavusoglu E., Ruwende C., Eng C., Chopra V., Yanamadala S., Clark L.T., Pinsky D.J., and Marmur J.D. Usefulness of baseline plasma myeloperoxidase levels as an independent predictor of myocardial infarction at two years in patients presenting with acute coronary syndromes. Am J Cardiol 99 (2007) 1364-1368
15. Garcia-Gonzalez M.J., Dominguez-Rodriguez A., Santacreu Iniesta R., Samimi-Fard S., Ferrer-Hita J.J., Rubio-Iglesias Garcia C., and Abreu-Gonzalez P. Systemic inflammatory response syndrome: incidence and influence on outcome in acute myocardial infarction treated with primary angioplasty. Med Intensiva 31 (2007) 289-293
16. Saadeddin S.M., Habbab M.A., Sobki S.H., and Frens G.A. Association of systemic inflammatory state with troponin I elevation after elective uncomplicated percutaneous coronary intervention. Am J Cardiol 89 (2002) 981-983
17. Bodi V., Sanchis J., Nunez J., Mainar L., Minana G., Benet I., Solano C., Chorro F.J., and Llacer A. Uncontrolled immune response in acute myocardial infarction: unraveling the thread. Am Heart J 156 (2008) 1065-1073
18. Hall R.I., Smith M.S., and Rocker G. The systemic inflammatory response to cardiopulmonary bypass: pathophysiological, therapeutic, and pharmacological considerations. Anesth Analg 85 (1997) 766-782
19. Davies M.G., and Hagen P.O. Systemic inflammatory response syndrome. Br J Surg 84 (1997) 920-935
20. Libby P. Current concepts of the pathogenesis of the acute coronary syndromes. Circulation 104 (2001) 365-372
21. Baldus S., Heitzer T., Eiserich J.P., Lau D., Mollnau H., Ortak M., Petri S., Goldmann B., Duchstein H.J., Berger J., Helmchen U., Freeman B.A., Meinertz T., and Munzel T. Myeloperoxidase enhances nitric oxide catabolism during acute myocardial ischemia and reperfusion. Free Radic Biol Med 37 (2004) 902-911
22. Nicholls S.J., and Hazen S.L. Myeloperoxidase and cardiovascular disease. Arterioscler Thromb Vasc Biol 25 (2005) 1102-1111
23. Askari A.T., Brennan M.L., Zhou X., Drinko J., Morehead A., Thomas J.D., Topol E.J., Hazen S.L., and Penn M.S. Myeloperoxidase and plasminogen activator inhibitor 1 play a central role in ventricular remodeling after myocardial infarction. J Exp Med 197 (2003) 615-624
24. Mizock B.A., and Falk J.L. Lactic acidosis in critical illness. Crit Care Med 20 (1992) 80-93
25. Brugger-Andersen T., Hetland O., Ponitz V., Grundt H., and Nilsen D.W. The effect of primary percutaneous coronary intervention as compared to tenecteplase on myeloperoxidase, pregnancy-associated plasma protein A, soluble fibrin and D-dimer in acute myocardial infarction. Thromb Res 119 (2007) 415-421
26. Li G., Keenan A.C., Young J.C., Hall M.J., Pamuklar Z., Ohman E.M., Steinhubl S.R., and Smyth S.S. Effects of unfractionated heparin and glycoprotein IIb/IIIa antagonists versus bivalirudin on myeloperoxidase release from neutrophils. Arterioscler Thromb Vasc Biol 27 (2007) 1850-1856